<?xml version="1.0" encoding="UTF-8"?>
<ref id="ppat.1007395.ref007">
 <label>7</label>
 <mixed-citation publication-type="journal">
  <name>
   <surname>Ledgerwood</surname>
   <given-names>JE</given-names>
  </name>, 
  <name>
   <surname>Coates</surname>
   <given-names>EE</given-names>
  </name>, 
  <name>
   <surname>Yamshchikov</surname>
   <given-names>G</given-names>
  </name>, 
  <name>
   <surname>Saunders</surname>
   <given-names>JG</given-names>
  </name>, 
  <name>
   <surname>Holman</surname>
   <given-names>L</given-names>
  </name>, 
  <name>
   <surname>Enama</surname>
   <given-names>ME</given-names>
  </name>, 
  <etal>et al</etal>
  <article-title>Safety, pharmacokinetics and neutralization of the broadly neutralizing HIV-1 human monoclonal antibody VRC01 in healthy adults</article-title>. 
  <source>Clin Exp Immunol</source>. 
  <year>2015</year>;
  <volume>182</volume>: 
  <fpage>289</fpage>â€“
  <lpage>301</lpage>. 
  <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1111/cei.12692" xmlns:xlink="http://www.w3.org/1999/xlink">10.1111/cei.12692</ext-link>
  <?supplied-pmid 26332605?>
  <pub-id pub-id-type="pmid">26332605</pub-id>
 </mixed-citation>
</ref>
